BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36634852)

  • 1. Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.
    Chapman ER; Nicholls L; Suh YE; Khoo V; Levine D; Ap Dafydd D; Van As N
    Radiother Oncol; 2023 Mar; 180():109461. PubMed ID: 36634852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
    Gerlich AS; van der Velden JM; Kotte ANTJ; Tseng CL; Fanetti G; Eppinga WSC; Kasperts N; Intven MPW; Pameijer FA; Philippens MEP; Verkooijen HM; Seravalli E
    Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of
    Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
    Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
    Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
    Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT.
    Prins FM; van der Velden JM; Gerlich AS; Kotte ANTJ; Eppinga WSC; Kasperts N; Verlaan JJ; Pameijer FA; Kerkmeijer LGW
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S147-S154. PubMed ID: 28866897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
    Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Magnetic Resonance Imaging on Gross Tumor Volume Delineation in Non-spine Bony Metastasis Treated With Stereotactic Body Radiation Therapy.
    Raman S; Chin L; Erler D; Atenafu EG; Cheung P; Chu W; Chung H; Loblaw A; Poon I; Rubenstein J; Soliman H; Sahgal A; Tseng CL
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):735-743.e1. PubMed ID: 29748100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.
    Lütgendorf-Caucig C; Fotina I; Stock M; Pötter R; Goldner G; Georg D
    Radiother Oncol; 2011 Feb; 98(2):154-61. PubMed ID: 21176984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy.
    den Hartogh MD; Philippens ME; van Dam IE; Kleynen CE; Tersteeg RJ; Pijnappel RM; Kotte AN; Verkooijen HM; van den Bosch MA; van Vulpen M; van Asselen B; van den Bongard HD
    Radiat Oncol; 2014 Feb; 9():63. PubMed ID: 24571783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous
    Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
    Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
    Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dedicated MRI simulation for cervical cancer radiation treatment planning: Assessing the impact on clinical target volume delineation.
    Veera J; Lim K; Dowling JA; O'Connor C; Holloway LC; Vinod SK
    J Med Imaging Radiat Oncol; 2019 Apr; 63(2):236-243. PubMed ID: 30506944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
    Barkati M; Simard D; Taussky D; Delouya G
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):255-9. PubMed ID: 26568515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.
    Gkika E; Kostyszyn D; Fechter T; Moustakis C; Ernst F; Boda-Heggemann J; Sarria G; Dieckmann K; Dobiasch S; Duma MN; Eberle F; Kroeger K; Häussler B; Izaguirre V; Jazmati D; Lautenschläger S; Lohaus F; Mantel F; Menzel J; Pachmann S; Pavic M; Radlanski K; Riesterer O; Gerum S; Röder F; Willner J; Barczyk S; Imhoff D; Blanck O; Wittig A; Guckenberger M; Grosu AL; Brunner TB
    Strahlenther Onkol; 2023 Nov; 199(11):973-981. PubMed ID: 37268767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver variability in target volume delineation for CT/MRI simulation and MRI-guided adaptive radiotherapy in rectal cancer.
    White I; Hunt A; Bird T; Settatree S; Soliman H; Mcquaid D; Dearnaley D; Lalondrelle S; Bhide S
    Br J Radiol; 2021 Dec; 94(1128):20210350. PubMed ID: 34723622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition.
    Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA
    Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
    Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
    BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT).
    Dunne EM; Sahgal A; Lo SS; Bergman A; Kosztyla R; Dea N; Chang EL; Chang UK; Chao ST; Faruqi S; Ghia AJ; Redmond KJ; Soltys SG; Liu MC
    Radiother Oncol; 2020 Apr; 145():21-29. PubMed ID: 31874346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-observer variations of the tumor bed delineation for patients after breast conserving surgery in preoperative magnetic resonance and computed tomography scan fusion.
    Jiang J; Chen J; Li W; Li Y; Chen Y; Zhang Z; Liu C; Han D; Sun H; Li B; Huang W
    BMC Cancer; 2021 Jul; 21(1):838. PubMed ID: 34284752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.